Tazemetostat hydrobromide
|
|
- CAS-Nr.
- 1467052-75-0
- Englisch Name:
- Tazemetostat hydrobromide
- Synonyma:
- Tazemetostat HBr;E-7438 hydrobromide;EPZ-6438 hydrobromide;Tazemetostat hydrobromide;Tazemetostat hydrobromide (JAN/USAN);Tazemetostat hydrobromide, 10 mM in DMSO;Tazemetostat HBr,Tazemetostat hydrobromide;Tazemetostat hydrobromide (EPZ6438 or E7438);Tazemetostat hydrobromide (EPZ-6438 hydrobromide);Tazemetostat,E 7438,E7438,PRC2,Inhibitor,E-7438,epigenetic,EZH2,EPZ6438,EPZ-6438,Histone Methyltransferase,cancer,Tazemetostat hydrobromide,EPZ 6438,inhibit,EZH1
- CBNumber:
- CB14848188
- Summenformel:
- C34H45BrN4O4
- Molgewicht:
- 653.66
- MOL-Datei:
- 1467052-75-0.mol
|
Tazemetostat hydrobromide Eigenschaften
- storage temp.
- Store at -20°C
- L?slichkeit
- DMSO: 100 mg/mL (152.99 mM)
Sicherheit
Tazemetostat hydrobromide Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
Tazemetostat Hydrobromide is developed by Epizyme for the treatment of relapsed or refractory follicular lymphoma.
Trademarks
Tazverik
Tazemetostat hydrobromide Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Tazemetostat hydrobromide Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 33)Lieferanten
- Tazemetostat hydrobromide (JAN/USAN)
- Tazemetostat hydrobromide
- Tazemetostat hydrobromide (EPZ6438 or E7438)
- E-7438 hydrobromide
- EPZ-6438 hydrobromide
- Tazemetostat HBr,Tazemetostat hydrobromide
- Tazemetostat,E 7438,E7438,PRC2,Inhibitor,E-7438,epigenetic,EZH2,EPZ6438,EPZ-6438,Histone Methyltransferase,cancer,Tazemetostat hydrobromide,EPZ 6438,inhibit,EZH1
- N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4-methyl-4'-(morpholinomethyl)-[1,1'-biphenyl]-3-carboxamide hydrobromide
- Tazemetostat hydrobromide (EPZ-6438 hydrobromide)
- Tazemetostat HBr
- Tazemetostat hydrobromide, 10 mM in DMSO
- 1467052-75-0
- C34H44N4O4HBr